BeOne Medicines Partners with Revolution Medicines on RAS Cancer Therapies
San Carlos, Calif. & Redwood City, Calif., August 10, 2026 BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
San Carlos, Calif. & Redwood City, Calif., August 10, 2026 BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a...
BETHESDA, Md., August 6, 2026 Northwest Biotherapeutics announced that it has entered into a non-binding Memorandum of Understanding (MOU)...
Mequon, Wisconsin & Lenexa, Kansas, July 28, 2026 Vector Science & Therapeutics Corp., LyoGenesis Plus 1, LLC, and Wynn...
Cambridge, MA, Rotterdam, Netherlands, and Shanghai, China – July 27, 2026 Harbour BioMed has entered into a strategic collaboration...
Brisbane, California, USA | July 21, 2026 Nurix Therapeutics announced the official closing of its previously announced global collaboration...
SHANGHAI, China, July 8, 2026 OTR Therapeutics and LG Chem Life Sciences have announced a strategic collaboration to accelerate...
HONG KONG, July 2, 2026 CSPC Pharmaceutical Group Limited has announced a strategic collaboration, option and license agreement with...
SHANGHAI, June 23, 2026 Abbisko Therapeutics Co., Ltd. announced a strategic research collaboration and license agreement with Eli Lilly...
SOUTH SAN FRANCISCO, California, USA, June 3, 2026 CytomX Therapeutics has announced a significant expansion of its strategic research...
NEW YORK, SAN FRANCISCO, and SUZHOU, China, May 28, 2026 Pfizer Inc. and Innovent Biologics have announced a landmark...
